GLP-1 RAs in Patients With Polycystic Ovary Syndrome (PCOS)

PHASE4CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

May 15, 2021

Primary Completion Date

April 30, 2022

Study Completion Date

May 10, 2022

Conditions
Polycystic Ovary Syndrome
Interventions
DRUG

GLP-1 RAs

GLP-1 receptor agonist is a glucagon-like peptide 1 analog, which is related to improving blood sugar control, weight loss and appetite suppression, and reducing cardiovascular risk.

OTHER

calorie restricted diet

Calorie restricted diet can improve insulin sensitivity, liver fat in patients with visceral obesity, and metabolism and hormone levels in obese women with PCOS.

Trial Locations (1)

200072

Shanghai Tenth People' Hospital, Shanghai

All Listed Sponsors
lead

Shanghai 10th People's Hospital

OTHER